Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

Why I think the AstraZeneca share price could crush the FTSE 100 this year

| Peter Stephens

AstraZeneca plc (LON: AZN) appears to offer better value for money than the FTSE 100.

Read more »

Investing Articles

Will AstraZeneca continue to outperform in 2019?

| Andy Ross

Andy Ross sees plenty to be upbeat about at AstraZeneca plc (LON:AZN) that he thinks could keep it beating the…

Read more »

Investing Articles

Why I’d pick the GSK and AstraZeneca share prices to beat my State Pension

| Alan Oscroft

I'm looking to re-invest a company pension, and here's why AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) shares…

Read more »

Investing Articles

The AstraZeneca and GSK share prices look like buys to me as the FTSE 100 crashes

| Harvey Jones

Harvey Jones says AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) have the antidote to the current FTSE 100…

Read more »

Investing Articles

I think this FTSE 100 dividend stock could be poised for big gains in 2019

| Royston Wild

Royston Wild identifies a FTSE 100 (INDEXFTSE: UKX) income hero that could sprint still higher in 2019.

Read more »

Investing Articles

The AstraZeneca share price has smashed the FTSE 100 in 2018. I say it could do so again in 2019

| Rupert Hargreaves

Rupert Hargreaves explains why he thinks AstraZeneca plc (LON:AZN) will continue to outperform the FTSE 100 (INDEXFTSE: UKX).

Read more »

Investing Articles

Why I think AstraZeneca should be in your 2019 share portfolio

| Tezcan Gecgil, PhD

AstraZeneca plc (LON: AZN) has multiple positive catalysts and I see a buying opportunity right now.

Read more »

Investing Articles

3 FTSE 100 shares I think are better than a buy-to-let property

| Andy Ross

If you're thinking of investing in buy-to-let, these three stocks could be a better buy, says Andy Ross.

Read more »

Investing Articles

Could AstraZeneca boost your retirement income as the State Pension age rises?

| Peter Stephens

Could AstraZeneca plc’s (LON: AZN) dividend prospects help to offset the challenges posed by the State Pension?

Read more »

Investing Articles

Forget 1.5% from a cash ISA. FTSE 100 member AstraZeneca is up by 20% in 2018

| Roland Head

Roland Head asks whether FTSE 100 (INDEXFTSE:UKX) dividend stock AstraZeneca plc (LON:AZN) deserves a buy rating.

Read more »

Investing Articles

Don’t panic! How I think you can Brexit-proof your shares portfolio with these FTSE 100 dividend stocks

| Royston Wild

If you're worried about Brexit, then I think shopping for these FTSE 100 (INDEXFTSE: UKX) dividend stocks should be at…

Read more »

Investing Articles

Can the AstraZeneca share price continue to smash the FTSE 100?

| G A Chester

G A Chester discusses the valuation and prospects of FTSE 100 (INDEXFTSE:UKX) pharma stock AstraZeneca plc (LON:AZN).

Read more »